BUB1 and posterior cortical atrophy: To investigate the impact on clinical outcome of BUB1, which was significantly upregulated in PCa (Fig. 6A), we analyzed the disease-free interval and the progression-free interval of PCa patients acquired from TCGA PRAD dataset.